Heidi Jacobe

4.2k total citations
87 papers, 2.4k citations indexed

About

Heidi Jacobe is a scholar working on Pathology and Forensic Medicine, Dermatology and Genetics. According to data from OpenAlex, Heidi Jacobe has authored 87 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Pathology and Forensic Medicine, 30 papers in Dermatology and 14 papers in Genetics. Recurrent topics in Heidi Jacobe's work include Systemic Sclerosis and Related Diseases (53 papers), Autoimmune Bullous Skin Diseases (23 papers) and Dermatological and Skeletal Disorders (13 papers). Heidi Jacobe is often cited by papers focused on Systemic Sclerosis and Related Diseases (53 papers), Autoimmune Bullous Skin Diseases (23 papers) and Dermatological and Skeletal Disorders (13 papers). Heidi Jacobe collaborates with scholars based in United States, Canada and Germany. Heidi Jacobe's co-authors include Justin J. Leitenberger, Brittany A. Zwischenberger, Rachael Cayce, A. John Rush, Yonas Getachew, Marlyn J. Mayo, Sandra Saldana, Paul R. Bergstresser, Robert W. Haley and Beverley Adams‐Huet and has published in prestigious journals such as SHILAP Revista de lepidopterología, Hepatology and International Journal of Molecular Sciences.

In The Last Decade

Heidi Jacobe

81 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Heidi Jacobe United States 28 1.1k 1.1k 454 426 292 87 2.4k
M.F. Mohd Mustapa United Kingdom 21 330 0.3× 665 0.6× 340 0.7× 409 1.0× 294 1.0× 54 1.7k
Megha M. Tollefson United States 25 401 0.4× 804 0.7× 214 0.5× 449 1.1× 183 0.6× 105 1.9k
Dimitrios Rigopoulos Greece 26 401 0.4× 1.2k 1.1× 676 1.5× 669 1.6× 280 1.0× 140 2.2k
Natasha Atanaskova Mesinkovska United States 30 323 0.3× 1.5k 1.4× 326 0.7× 250 0.6× 198 0.7× 212 2.8k
Khalaf Kridin Israel 32 1.8k 1.6× 799 0.7× 312 0.7× 414 1.0× 1.4k 4.8× 197 3.3k
Carmela C. Vittorio United States 24 624 0.5× 1.2k 1.1× 617 1.4× 764 1.8× 532 1.8× 53 2.4k
A.J.G. McDonagh United Kingdom 26 339 0.3× 938 0.8× 266 0.6× 370 0.9× 219 0.8× 63 2.1k
Andrea Peserico Italy 33 491 0.4× 1.5k 1.3× 664 1.5× 1.2k 2.8× 512 1.8× 138 3.5k
Michael David Israel 20 372 0.3× 790 0.7× 291 0.6× 480 1.1× 301 1.0× 67 1.9k
Matteo Megna Italy 36 551 0.5× 2.3k 2.0× 495 1.1× 2.1k 4.8× 416 1.4× 249 4.1k

Countries citing papers authored by Heidi Jacobe

Since Specialization
Citations

This map shows the geographic impact of Heidi Jacobe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heidi Jacobe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heidi Jacobe more than expected).

Fields of papers citing papers by Heidi Jacobe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heidi Jacobe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heidi Jacobe. The network helps show where Heidi Jacobe may publish in the future.

Co-authorship network of co-authors of Heidi Jacobe

This figure shows the co-authorship network connecting the top 25 collaborators of Heidi Jacobe. A scholar is included among the top collaborators of Heidi Jacobe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heidi Jacobe. Heidi Jacobe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
García‐Romero, María Teresa, Megha M. Tollefson, Elena Pope, et al.. (2023). Development and Validation of the Morphea Activity Measure in Patients With Pediatric Morphea. JAMA Dermatology. 159(3). 299–299. 6 indexed citations
3.
Zigler, Christina K., Li Lin, Kaveh Ardalan, et al.. (2023). Cross‐sectional quantitative validation of the paediatric Localized Scleroderma Quality of Life Instrument (LoSQI): A disease‐specific patient‐reported outcome measure. Journal of the European Academy of Dermatology and Venereology. 37(7). 1406–1414. 4 indexed citations
4.
Martyanov, Viktor, Lam C. Tsoi, Michael E. Johnson, et al.. (2023). Gene Expression Signatures in Inflammatory and Sclerotic Morphea Skin and Sera Distinguish Morphea from Systemic Sclerosis. Journal of Investigative Dermatology. 143(10). 1886–1895.e10. 8 indexed citations
5.
Epstein, Joshua, et al.. (2023). Clinical Characteristics Associated with Musculoskeletal Extracutaneous Manifestations in Pediatric and Adult Morphea: A Prospective, Cohort Study. Journal of Investigative Dermatology. 143(10). 1955–1963.e3. 5 indexed citations
6.
Bermas, Bonnie L., et al.. (2022). Morphea disease activity during pregnancy: A case series. The Journal of Dermatology. 49(12). 1278–1283.
7.
Foster, Jenny, et al.. (2022). Current Utilization of Qualitative Methodologies in Dermatology: A Scoping Review. SHILAP Revista de lepidopterología. 3(2). 100172–100172. 3 indexed citations
8.
Paniagua, Ricardo, Stephanie Florez-Pollack, Quan‐Zhen Li, et al.. (2022). Autoantigen microarrays reveal myelin basic protein autoantibodies in morphea. Journal of Translational Medicine. 20(1). 41–41. 1 indexed citations
9.
Saag, Kenneth G., T. J. de Villiers, Peter Alexandersen, et al.. (2020). Morphea-like skin lesions reported in the phase 3 Long-Term Odanacatib Fracture Trial (LOFT) in postmenopausal women with osteoporosis. Journal of the American Academy of Dermatology. 84(4). 1113–1119. 2 indexed citations
10.
Tabib, Tracy, Xinjun Wang, Wei Chen, et al.. (2020). Single-cell transcriptome conservation in a comparative analysis of fresh and cryopreserved human skin tissue: pilot in localized scleroderma. Arthritis Research & Therapy. 22(1). 101–101. 31 indexed citations
11.
Zigler, Christina K., Heidi Jacobe, Kaveh Ardalan, et al.. (2020). The importance of development standards for anchoring vignettes: an illustrative example from pediatric localized scleroderma quality of life. Quality of Life Research. 29(12). 3263–3272. 4 indexed citations
12.
Jacobe, Heidi, et al.. (2019). Using the Localized Scleroderma Cutaneous Assessment Tool (Lo SCAT ) to classify morphoea by severity and identify clinically significant change. British Journal of Dermatology. 182(2). 398–404. 15 indexed citations
13.
Paniagua, Ricardo, et al.. (2018). 027 Myelin basic protein antibodies as a biomarker in morphea. Journal of Investigative Dermatology. 138(5). S5–S5. 3 indexed citations
14.
Cyrus, Nika, et al.. (2017). 288 Immune dysregulation in morphea. Journal of Investigative Dermatology. 137(5). S49–S49. 2 indexed citations
15.
Cruz, Ponciano D., et al.. (2016). Myeloid-Derived Suppressor Cells in Psoriasis Are an Expanded Population Exhibiting Diverse T-Cell–Suppressor Mechanisms. Journal of Investigative Dermatology. 136(9). 1801–1810. 45 indexed citations
16.
Jacobe, Heidi, et al.. (2016). Phototherapy for sclerosing skin conditions. Clinics in Dermatology. 34(5). 614–622. 15 indexed citations
17.
Das, Shinjita, Ira H. Bernstein, & Heidi Jacobe. (2014). Correlates of self-reported quality of life in adults and children with morphea. Journal of the American Academy of Dermatology. 70(5). 904–910. 42 indexed citations
18.
19.
Mayo, Marlyn J., et al.. (2007). Sertraline as a first-line treatment for cholestatic pruritus. Hepatology. 45(3). 666–674. 203 indexed citations
20.
Tuchinda, Chanisada, Holly Kerr, Charles R. Taylor, et al.. (2006). UVA1 phototherapy for cutaneous diseases: an experience of 92 cases in the United States. Photodermatology Photoimmunology & Photomedicine. 22(5). 247–253. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M.F. Mohd Mustapa Breakdown of academic impact, for papers by Megha M. Tollefson Breakdown of academic impact, for papers by Dimitrios Rigopoulos Breakdown of academic impact, for papers by Natasha Atanaskova Mesinkovska Breakdown of academic impact, for papers by Khalaf Kridin Breakdown of academic impact, for papers by Carmela C. Vittorio Breakdown of academic impact, for papers by A.J.G. McDonagh Breakdown of academic impact, for papers by Andrea Peserico Breakdown of academic impact, for papers by Michael David Breakdown of academic impact, for papers by Matteo Megna
Rankless by CCL
2026